Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years

Submitted by admin on September 30, 2024 - 9:28am

Source:

Medical Marketing and Media

News Tags:

Bristol Myers Squibb

FDA

schizophrenia

Cobenfy

Headline:

Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years

snippet:

Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.

Search form

You are here

Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years

Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years